Clinical Acquired Resistance to RAF Inhibitor Combinations in BRAF-Mutant Colorectal Cancer through MAPK Pathway Alterations-Reference-Cited by-同舟云学术

Clinical Acquired Resistance to RAF Inhibitor Combinations in BRAF-Mutant Colorectal Cancer through MAPK Pathway Alterations

Published:2015-02-11 Issue:4 Volume:5 Page:358-367
ISSN:2159-8274
Container-title:Cancer Discovery
language:en
Short-container-title:Cancer Discovery

Author:

Ahronian Leanne G.,Sennott Erin M.,Van Allen Eliezer M.,Wagle Nikhil,Kwak Eunice L.,Faris Jason E.,Godfrey Jason T.,Nishimura Koki,Lynch Kerry D.,Mermel Craig H.,Lockerman Elizabeth L.,Kalsy Anuj,Gurski Joseph M.,Bahl Samira,Anderka Kristin,Green Lisa M.,Lennon Niall J.,Huynh Tiffany G.,Mino-Kenudson Mari,Getz Gad,Dias-Santagata Dora,Iafrate A. John,Engelman Jeffrey A.,Garraway Levi A.,Corcoran Ryan B.

Publisher

American Association for Cancer Research (AACR)

Subject

Oncology

Cited by 266 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence of KRAS amplification in patients with metastatic cancer: Real-world next-generation sequencing analysis;Pathology - Research and Practice;2024-09

2. BRAF-Mutant Metastatic Colorectal Cancer: Current Evidence, Future Directions, and Research Priorities;Clinical Colorectal Cancer;2024-09

3. Case report: Metastatic BRAF V600E–mutated adult Wilms’ tumor with robust response to BRAF/MEK inhibitor therapy;Frontiers in Oncology;2024-07-15

4. Current State of Targeted Therapy in Adult Langerhans Cell Histiocytosis and Erdheim–Chester Disease;Targeted Oncology;2024-07-11

5. Exploring the integration of nanotechnology in the development and application of biosensors for enhanced detection and monitoring of colorectal cancer;Inorganic Chemistry Communications;2024-06